Goldman Sachs’s Viveon Health Acquisition Corp. VHAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-287,864
Closed -$2.88M 7007
2021
Q4
$2.88M Sell
287,864
-230,933
-45% -$2.31M ﹤0.01% 3927
2021
Q3
$5.18M Sell
518,797
-2,353
-0.5% -$23.4K ﹤0.01% 3336
2021
Q2
$5.16M Sell
521,150
-2,500
-0.5% -$24.8K ﹤0.01% 3310
2021
Q1
$5.14M Buy
+523,650
New +$5.23M ﹤0.01% 3112

Other funds holding VHAQ

Goldman Sachs's VHAQ Position: Q1 2022 in Review

Goldman Sachs sold out of Viveon Health Acquisition Corp. (VHAQ) in Q1 2022, closing a stake of 287,864 shares — an estimated $2.88M sold.

Goldman Sachs first reported a position in VHAQ in Q1 2021 and held it in 4 quarters. The position peaked at $5.18M in Q3 2021. 27 funds tracked by Wall St. Rank hold VHAQ as of Q1 2022.

  • Goldman Sachs reported no remaining Viveon Health Acquisition Corp. position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 287,864 Viveon Health Acquisition Corp. shares in Q1 2022, an estimated $2.88M.
  • Goldman Sachs first reported a position in Viveon Health Acquisition Corp. in Q1 2021 and held it in 4 quarters.
  • Goldman Sachs's Viveon Health Acquisition Corp. position peaked at $5.18M in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.